V4758
血管内皮生长因子单克隆抗体 小鼠抗
clone 26503, purified immunoglobulin, lyophilized powder
别名:
抗VEGF
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Conjugate:
unconjugated
Clone:
26503, monoclonal
Application:
ELISA (c), Neutral, WB
Citations:
14
Quality Level
biological source
mouse
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
26503, monoclonal
form
lyophilized powder
species reactivity
primate, human
technique(s)
capture ELISA: 2-8 μg/mL, neutralization: suitable, western blot: 1 μg/mL
isotype
IgG2b
UniProt accession no.
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... VEGFA(7422), VEGFB(7423), VEGFC(7424)
General description
该抗体能够中和重组人VEGF165的生物活性。它也能识别VEGF121。
Immunogen
纯化的重组 Sf21-源性人VEGF（165 aa亚型）。
Application
小鼠抗血管内皮生长因子单克隆抗体被用于阻断小牛肺主动脉内皮（CPAE）细胞中VEGF和激酶结构域受体之间的相互作用。
成功使用该抗体的应用以及相关的同行评审论文如下所示。
蛋白质免疫印迹分析（1篇论文）
蛋白质免疫印迹分析（1篇论文）
Biochem/physiol Actions
血管内皮生长因子家族包括五个成员，即从VEGF-A到VEGF-E。它们在胚胎血管形成、血管生成和内稳态中具有重要作用。VEGF与其各自受体之间的相互作用，可激活MAPK、PI3K、PKC、FAK和Src激酶途径。
Physical form
冻干品来自于以磷酸盐缓冲盐水（含碳水化合物）为溶剂的0.2μm溶液。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
低风险生物材料
常规特殊物品
此项目有
Dong-Kwon Lim et al.
Biomaterials, 77, 130-138 (2015-11-21)
Vascular endothelial growth factor 165 (VEGF165) is an important extracellular protein involved in pathological angiogenesis in diseases such as cancer, wet age-related macular degeneration (wet-AMD) and retinitis pigmentosa. VEGF165 exists in two different isoforms: the angiogenic VEGF165a, and the anti-angiogenic
R Binétruy-Tournaire et al.
The EMBO journal, 19(7), 1525-1533 (2000-04-04)
Vascular endothelial growth factor (VEGF) binding to the kinase domain receptor (KDR/FLK1 or VEGFR-2) mediates vascularization and tumor-induced angiogenesis. Since there is evidence that KDR plays an important role in tumor angiogenesis, we sought to identify peptides able to block
Esther Grueso et al.
Journal of virology, 93(19) (2019-07-19)
As many tumor cells synthetize vascular endothelial growth factors (VEGF) that promote neo-vascularization and metastasis, frontline cancer therapies often administer anti-VEGF (α-VEGF) antibodies. To target the oncolytic parvovirus minute virus of mice (MVM) to the tumor vasculature, we studied the
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| V4758-.5MG | 04061832717555 |